Cancer of Kidney

14 registered clinical trials studyying Cancer of Kidney — 3 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	Psilocybin-Assisted Psychotherapy in Cancer Patients With Adjustment Disorder NCT07072728	Psyence Australia Pty Ltd	Phase 2
Unknown	Valveless Trocar Versus Standard Trocar in Robot-assisted Complex Partial Nephrectomy NCT05732857	Regina Elena Cancer Institute	N/A
Not Yet Recruiting	Cabo-POLARIS : A Trial to Evaluate Cabozantinib Among Haemodialysied Patients NCT05241561	Centre Hospitalier Universitaire de Besancon	Phase 2
Completed	A Study to Describe the Kidney Cancer Patient Population Treatment, and Results in the Hospital District of So NCT05363072	Pfizer	—
Active Not Recruiting	Tempus Priority Study: A Pan-tumor Observational Study NCT05179824	Tempus AI	—
Withdrawn	Low-moderate Intensity Pedaling During Immunotherapy Administration NCT04127318	Rush University Medical Center	N/A
Unknown	The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor NCT03896958	SpeciCare	—
Recruiting	SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry NCT03452774	Massive Bio, Inc.	—
Completed	Radiotherapy Assessments During Intervention ANd Treatment (RADIANT) NCT03133286	DxTerity Diagnostics	—
Terminated	MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors NCT02669914	Washington University School of Medicine	Phase 2
Completed	Identification of Risk Factors Associated With Neoplastic Complications After Renal Transplantation in Nord-Pa NCT02121730	Centre Hospitalier Universitaire, Amiens	—
Terminated	Microwave Coagulation in Partial Nephrectomy Protocol NCT01931462	University of Wisconsin, Madison	N/A
Completed	A Pharmacodynamic Study of Sirolimus and Metformin in Patients With Advanced Solid Tumors NCT02145559	University of Chicago	Phase 1
Completed	Safety Study With the Antibody, cG250, and Isotope, 124-Iodine, to Diagnose Patients With Renal Masses. NCT00199888	Ludwig Institute for Cancer Research	Phase 1